Position in MRK
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$150,309,277
-$3,001,049 QoQ
Shares Held
1,169,722
-8.2% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
1.65%
of 13F equity value
Holder Rank
#3
of 371 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 85.0643999172453.ToString("F0")%
Shared 0.ToString("F0")%
None 14.935600082754705.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KAMES CAPITAL plc holds $1,010,877,249 across 9 Drug Manufacturers - General names. MRK ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,905,111 | $361,247,147 | |
| 2 | ABBV |
AbbVie Inc.
|
680,730 | $171,298,897 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
1,169,722 | $150,309,277 | |
| 4 | JNJ |
Johnson & Johnson
|
443,703 | $112,687,250 | |
| 5 | LLY |
ELI LILLY & Co
|
81,026 | $97,185,023 | |
| 6 | BIIB |
Biogen Inc.
|
241,101 | $52,092,282 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
635,252 | $36,603,220 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
192,146 | $24,275,725 |
All Filings in MRK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $150,309,277 | 1,169,722 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $153,310,326 | 1,274,506 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $136,812,527 | 1,299,758 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $105,946,937 | 1,262,325 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $105,498,352 | 1,332,723 | Shares | Sole | 2026-04-10 | |
| 2025-03-31 | $111,439,194 | 1,241,524 | Shares | Sole | 2026-04-10 | |
| 2024-12-31 | $100,071,806 | 1,005,949 | Shares | Sole | 2026-04-10 | |
| 2024-09-30 | $131,890,968 | 1,161,421 | Shares | Sole | 2026-04-10 | |
| 2024-06-30 | $150,556,522 | 1,216,127 | Shares | Sole | 2026-04-10 | |
| 2024-03-31 | $219,102,975 | 1,660,500 | Shares | Sole | 2026-04-10 | |
| 2023-12-31 | $187,042,125 | 1,715,668 | Shares | Sole | 2026-04-10 | |
| 2023-06-30 | $185,507,887 | 1,607,660 | Shares | Sole | 2026-04-10 | |
| 2023-03-31 | $120,758,714 | 1,135,057 | Shares | Sole | 2025-09-02 | |
| 2022-12-31 | $138,674,075 | 1,249,879 | Shares | Sole | 2023-10-19 | |
| 2022-09-30 | $107,639,579 | 1,249,879 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $129,677,017 | 1,422,365 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $105,370,415 | 1,284,222 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $27,422,864 | 357,814 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $28,523,322 | 379,754 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $29,173,082 | 375,120 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $29,745,575 | 404,376 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $45,374,548 | 581,327 | Shares | Sole | 2021-01-25 | |
| No filing history on record for this holder in this stock. | ||||||